http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021006839-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aace38bda671c382395f1afba002cd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7afcd5681262d8e630211827098c7cf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2205-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-0281
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
filingDate 2020-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ad24a10fa2d2b1a6388a36ee0b203ad
publicationDate 2021-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021006839-A1
titleOfInvention Method for obtaining solid plasma as a filling material
abstract The invention is a method of obtaining a solid plasma (100) for use as a filling material in anti-aging applications in medical aesthetics field and in filling method applied to restore the shape of the deformed area as a result of deformation occurring in the body, which is completely obtained from human blood instead of chemical substances, in which blood samples (2) taken into the glass blood collection tubes (1), are dissociated into plasma (3), thrombocyte (4), red blood cells (6) and leukocytes (7) by centrifugation (101), wherein the method comprises the process steps of after performing the said dissociation process with centrifugation (101), dissociating the plasma (3) and thrombocyte (4) from red blood cells (6) and leukocytes (7) by means of a filter (5) (102), placing the dissociatied plasma (3) and thrombocyte (4) in the incubation device (8) by mixing, holding it at the determined temperature and time intervals, and holding it until the time expires (104) and as a result of the holding time taking it from the incubation device (8) as ready-to-use solid plasma (9) to be used as filling material.
priorityDate 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018102909-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014126931-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9722245-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0442114-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81070
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466

Total number of triples: 26.